Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 1861 AL 1875

Alzheimer's Disease and Effects of ABCA7 Polymorphisms: A Review

Gialama V, Siokas V, Liampas I, Tsouris Z, Stamati P, Aslanidou P, Provatas A, Tsimourtou V, Xiromerisiou G, Bogdanos DP, Dardiotis E.

J Integr Neurosci. 2024 Sep 6;23(9):164. doi: 10.31083/j.jin2309164.

Therapeutic Efficacy of Extracellular Vesicles Derived from Stem Cell for Alzheimer's Disease: A Meta-Analysis Study

Deng H, Zhao J, Li J, Chen C, Hu Z, Wu X, Ge L.

Front Biosci (Landmark Ed). 2024 Sep 25;29(9):340. doi: 10.31083/j.fbl2909340.

Naringin and Naringenin: Potential Multi-Target Agents for Alzheimer's Disease

Lu J, Chen J, Li SY, Pan GJ, Ou Y, Yuan LF, Jiang JP, Zeng LH, Zhao J.

Curr Med Sci. 2024 Oct;44(5):867-882. doi: 10.1007/s11596-024-2921-z. Epub 2024 Sep 30.

Progress in the Treatment of Alzheimer's Disease Is Needed - Position Statement of European Alzheimer's Disease Consortium (EADC) Investigators

Jessen F, Kramberger MG, Angioni D, Aarsland D, Balasa M, Bennys K, Boada M, Boban M, Chincarini A, Exalto L, Felbecker A, Fliessbach K, Frisoni GB, Garza-Martínez AJ, Grimmer T, Hanseeuw B, Hort J, Ivanoiu A, Klöppel S, Krajcovicova L, McGuinness B, Mecocci P, de Mendonca A, Nous A, Ousset PJ, Paquet C, Perneczky R, Peters O, Tabuas-Pereira M, Piazza F, Plantone D, Riverol M, Ruiz A, Sacco G, Santana I, Scarmeas N, Solje E, Stefanova E, Sutovsky S, van der Flier W, Welsh T, Wimo A, Winblad B, Frölich L, Engelborghs S.

J Prev Alzheimers Dis. 2024;11(5):1212-1218. doi: 10.14283/jpad.2024.153.

Semorinemab Pharmacokinetics and The Effect on Plasma Total Tau Pharmacodynamics in Clinical Studies

Ramakrishnan V, Bender B, Langenhorst J, Magnusson MO, Dolton M, Shim J, Fuji RN, Monteiro C, Teng E, Kassir N, Jin J.

J Prev Alzheimers Dis. 2024;11(5):1241-1250. doi: 10.14283/jpad.2024.146.

A review on synthetic inhibitors of dual-specific tyrosine phosphorylation-regulated kinase 1A (DYRK1A) for the treatment of Alzheimer's disease (AD)

Gehlot P, Pathak R, Kumar S, Choudhary NK, Vyas VK.

Bioorg Med Chem. 2024 Nov 1;113:117925. doi: 10.1016/j.bmc.2024.117925. Epub 2024 Sep 14.

Inflammatory proteins associated with Alzheimer's disease reduced by a GLP1 receptor agonist: a post hoc analysis of the EXSCEL randomized placebo controlled trial

Koychev I, Reid G, Nguyen M, Mentz RJ, Joyce D, Shah SH, Holman RR.

Alzheimers Res Ther. 2024 Oct 2;16(1):212. doi: 10.1186/s13195-024-01573-x.

Gut microbiota and Alzheimer's disease: Exploring natural product intervention and the Gut-Brain axis for therapeutic strategies

Pasupalak JK, Rajput P, Gupta GL.

Eur J Pharmacol. 2024 Dec 5;984:177022. doi: 10.1016/j.ejphar.2024.177022. Epub 2024 Oct 1.

Mitochondrial dysfunction gene expression, DNA methylation, and inflammatory cytokines interaction activate Alzheimer's disease: a multi-omics Mendelian randomization study

Zhang XX, Wei M, Wang HR, Hu YZ, Sun HM, Jia JJ.

J Transl Med. 2024 Oct 3;22(1):893. doi: 10.1186/s12967-024-05680-z.

Orexin Receptor Antagonists for the Prevention and Treatment of Alzheimer's Disease and Associated Sleep Disorders

Carpi M, Mercuri NB, Liguori C.

Drugs. 2024 Nov;84(11):1365-1378. doi: 10.1007/s40265-024-02096-3. Epub 2024 Oct 4.

Examining resilience to Alzheimer's disease through the lens of monoaminergic neuromodulator systems

Crawford JL, Berry AS.

Trends Neurosci. 2024 Nov;47(11):892-903. doi: 10.1016/j.tins.2024.09.004. Epub 2024 Oct 4.

β-amyloid's neurotoxic mechanisms as defined by in vitro microelectrode arrays: a review

O'Connell A, Quinlan L, Kwakowsky A.

Pharmacol Res. 2024 Nov;209:107436. doi: 10.1016/j.phrs.2024.107436. Epub 2024 Oct 4.

Free radicals in Alzheimer's disease: From pathophysiology to clinical trial results

Viña J, Borrás C, Mas-Bargues C.

Free Radic Biol Med. 2024 Nov 20;225:296-301. doi: 10.1016/j.freeradbiomed.2024.09.051. Epub 2024 Oct 5.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias